Skip to content

Drug interactions

Mifepristone + Mirvetuximab soravtansine

Severity: Moderate

Mifepristone and Mirvetuximab soravtansine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Mifepristone inhibits CYP3A4 and may raise exposure to DM4, the cytotoxic payload of mirvetuximab soravtansine. This may increase toxicities such as ocular and neuropathic effects.

What this interaction means in plain words

Mifepristone and Mirvetuximab soravtansine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mifepristone belongs to Endocrine; Mirvetuximab soravtansine belongs to Oncology.

Evidence level: Low

Why it happens

Mifepristone inhibits CYP3A4 metabolism of free DM4.

What to do

Monitor closely for adverse reactions including ocular toxicity and neuropathy. Consider an alternative to mifepristone if feasible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mifepristone and Mirvetuximab soravtansine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Mifepristone with Mirvetuximab soravtansine?

MediHelp rates the interaction as moderate. Mifepristone and Mirvetuximab soravtansine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Mifepristone inhibits CYP3A4 and may raise exposure to DM4, the cytotoxic payload of mirvetuximab soravtansine. This may increase toxicities such as ocular and neuropathic effects.

How serious is the interaction between Mifepristone and Mirvetuximab soravtansine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor closely for adverse reactions including ocular toxicity and neuropathy. Consider an alternative to mifepristone if feasible.

What other medicines interact with Mifepristone?

MediHelp also lists interactions of Mifepristone with, for example, Apixaban, Argatroban, Cisapride. The full list is on the Mifepristone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in